About

Sayre Therapeutics was founded in 2015 backed by leading institutional investors.

The team boasts 25 years of global executive experience in leading Pharmaceutical, Medical Diagnostics & Devices companies. Sayre Therapeutics has been identified as a high potential healthcare company, a pedigree team with proven wins and a robust clinician network in the Oncology / Immunology space. The company is uniquely positioned with a first-mover advantage, which allows for it to quickly create a portfolio of differentiated global assets in emerging markets.

Sayre is backed by two leading venture capital firms (VCs).

Our geographic footprint covers India, South Asian and South-East Asian countries which are witnessing a high growth rate across the disease areas of interest. Sayre Therapeutics with its focused strategy, strong financial backing and established relationships with clinicians and regulatory know-how, will be nimble and to that end, will prove to be a committed partner to licensors for their global assets.

Vision

We will become Asia’s specialized healthcare company of choice, providing patients and clinicians access to high-quality novel medical solutions for life-threatening diseases.

Mission

Leading the way by providing access to innovative and affordable treatment options, to improve the quality of life.

People

Shukrit Sudhir Chimote

Chief Executive Officer

Shukrit has a proven track record in the pharmaceutical industry and prior to founding Sayre Therapeutics, he served as Vice-President and India / South-Asia Head, Branded Formulations at Biocon, Bangalore, India. His responsibilities spanned the breadth of commercial operations including P&L management. Additionally, he headed global business development for the vertical, and directed strategies across eight business units, driving global in-licensing for them. His earlier roles at the premier Indian biotech included heading the Novel Medicines out-licensing and Biosimilars’ verticals.

In prior stints, Shukrit was employed with Bristol-Myers Squibb, Princeton, New Jersey, US in roles within the Anti-infectives, Cardiology and Immunology franchises. He was also part of the global marketing team where he facilitated the go-to-market strategies for Japan, China, S-E Asia and Indian markets, for a key Immunology first-in-class biological asset.

Shukrit’ s experience set over twenty five years in corporate and academia covers R&D strategy, analytics/market-research, global and in-line marketing and global business development. Shukrit is credited with building robust business lines in India, and drove the commercial strategy for global brands in the US.

Shukrit completed his Bachelor’s degree in Pharmacy from Mumbai, India and his MS in Pharmacology & an MBA in Pharmaceutical marketing from the University of Mississippi, US. He also has a Masters in International affairs from SIPA @ Columbia University, New York. He is married with two kids. Loves sushi and poha, keeps abreast of current political affairs, dreams of being fit and is a voracious TV watcher.

Rajesh Sasidharan

Head, Finance & Administration

Rajesh comes with 13 plus years of experience across different functions in the pharmaceutical industry with deep experience in Finance and Administration. Prior to joining Sayre, he has worked with Biocon and has received awards for excellence in Oncology.

At Sayre he is part of the core leadership team and is a founding member. He is a highly organized and creative problem solver who excels at guiding teams through challenging projects. He is responsible for business operations, finance, and administration. He exhibits a can-do attitude and drives with passion and purpose in Sayre’s fast-paced cross-functional environment.

He holds an MBA in HR and Administration. His hobbies include playing badminton, listening to music, and reading.